SCHEMBL9364720

SCHEMBL9364720

CC(=O)c1cc2c(cc1C#N)[nH]c(=O)c(=O)n2O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 3/20 0.35
HSD17B10 Q99714 1/20 0.35
GRIA1 P42261 3/20 0.35
GRIA2 P42262 3/20 0.35
GRIA3 P42263 3/20 0.35
GRIA4 P48058 3/20 0.35
CYP1A2 P05177 1/20 0.35
MAPT P10636 1/20 0.35
ALOX15 P16050 1/20 0.35
GRIN2D O15399 2/20 0.35
GRIN3B O60391 2/20 0.35
GRIN1 Q05586 2/20 0.35
GRIN2A Q12879 2/20 0.35
GRIN2B Q13224 2/20 0.35
GRIN2C Q14957 2/20 0.35
GRIN3A Q8TCU5 2/20 0.35
ALDH1A1 P00352 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9364584 0.84 GRIA1 (0.41) KDM4EGRIA1GRIA2GRIA3GRIA4
SCHEMBL9365335 0.79 GRIA1 (0.45) GRIA1GRIA2GRIA3GRIA4CYP1A2
SCHEMBL9091900 0.73 GRIA1 (0.40) MEN1KMT2AKDM4EGRIA1GRIA2
SCHEMBL9365531 0.70 FASN (0.44) L3MBTL1
SCHEMBL9364622 0.70 GRIN2D (0.58) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL9362564 0.69 DAO (0.35) L3MBTL1MEN1KMT2AKDM4EHSD17B10
SCHEMBL4704409 0.66 GRIA1 (0.64) MEN1KMT2AKDM4EHSD17B10GRIA1
SCHEMBL9368432 0.66 GRIN2D (0.56) KDM4EHSD17B10GRIN2DGRIN3BGRIN1
SCHEMBL9364640 0.65 DAO (0.39) KDM4EGRIA1GRIA2GRIA3GRIA4
SCHEMBL4514368 0.64 KDM4E (0.50) L3MBTL1MEN1KMT2AKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0377112-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-08-24 EP claimed
US-5061706-A 2,3-QUINOXALINEDIONES FOR USE AS NEUROLEPTICS NOVO NORDISK A/S (DK) 1991-10-29 US claimed
EP-0377112-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-08-24 EP disclosed
US-5061706-A 2,3-QUINOXALINEDIONES FOR USE AS NEUROLEPTICS NOVO NORDISK A/S (DK) 1991-10-29 US disclosed
EP-0377112-A1 Quinoxaline compounds and their preparation and use NOVO NORDISK A/S (DK) 1990-07-11 EP disclosed